Ascendis Pharma Non-Current Deferred Revenue (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

210.48 +7.49 (+3.69%) USD | NASDAQ | Jan 12, 11:26

View Non-Current Deferred Revenue (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	--
Evaxion AS	--
DBV Technologies SA	--
Cellectis SA	--
Biodexa Pharmaceuticals Plc	--